Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

Market Cap	13.50B
Revenue (ttm)	4.49B
Net Income (ttm)	-885.33M
Shares Out	4.27B
EPS (ttm)	-0.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,937,993
Average Volume	852,564
Open	3.000
Previous Close	3.160
Day's Range	2.900 - 3.180
52-Week Range	1.510 - 3.800
Beta	0.17
RSI	65.25
Earnings Date	Apr 30, 2025

About NGX:NEIMETH

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health care products in Nigeria and Ghana. The company operates through two segments, Pharmaceuticals and Animal Health. It also provides health care, ethical, and veterinary related products; and poultry and a range of anthelmintic products, as well as enhancing medicaments. The company was formally known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated...

• Industry: Pharmaceutical Preparations
• Founded: 1957
• Employees: 196
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: NEIMETH

Financial Performance

In 2024, NGX:NEIMETH's revenue was 4.49 billion, an increase of 102.98% compared to the previous year's 2.21 billion. Losses were -885.33 million, -50.75% less than in 2023.